Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia

Clinical Science

Volumn 100, Issue 2, 2001, Pages 191-198

  Stefanutti, C ^a   Di Giacomo, S ^a   Vivenzio, A ^a   Isacchi, G C ^a   Masella, R ^a   Caprari, P ^a   Vari R ^a   Tarzia, A ^a   Mosiello, A ^a   Cantafora, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hypercholesterolaemia; LDL oxidation; LDL apheresis; Oxidative damage; Reduced glutathione

Indexed keywords

ARYLDIALKYLPHOSPHATASE; AUTOANTIBODY; CELLULOSE; DEXTRAN SULFATE; HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; ANTIBODY DETECTION; APHERESIS; ARTICLE; ATHEROSCLEROSIS; CHILD; CLINICAL ARTICLE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ERYTHROCYTE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; LIPID OXIDATION; MALE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, AGAR GEL; ERYTHROCYTES; FATTY ACIDS, UNSATURATED; FEMALE; GLUTATHIONE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PLASMAPHERESIS;

EID: 17744380216     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000128     Document Type: Article

References (41)

1. Oxidized lipoproteins, altered cell function and atherosclerosis
2. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
3. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl esters
4. Oxidized lipoproteins in atherosclerosis and thrombosis
5. The LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
6. LDL-apheresis reduces the susceptibility of LDL to in vitro oxidation in a diabetic patient with haemodialysis treatment
7. Decreased low density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
8. Decreased susceptibility of low density lipoproteins to in vitro oxidation after dextransulphate LDL-apheresis treatment
9. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches
10. Activity of free radical scavenging enzymes in red cells and plasma of patients undergoing extracorporeal low-density lipoprotein apheresis
11. Glutathione in human plasma: Decline in association with aging, age-related macular degeneration, and diabetes
12. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man
13. Glutathione-related antioxidant defences in human atherosclerotic plaques
14. Lipoprotein and haemocoagulatory parameters during therapeutic plasmapheresis in homozygous and heterozygous familial hypercholesterolemia
15. Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL apheresis
16. LDL apheresis in pediatric patients with severe hyperlipoproteinemia
17. Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia
18. Comparison between different techniques of LDL apheresis
19. Reduced glutathione (GSH)
20. Recommendations for reference method for haemoglobinometry in human blood and specifications for international haemocyanide reference preparation
21. Adenosine 5′-triphosphate determination with phosphoglycerate kinase
22. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
23. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipids
24. Spectrophotometric assay of lipid peroxides in serum lipoproteins using a commercially available reagent
25. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
26. Elevated serum neopterin levels in atherosclerosis
27. A simple method for isolation and purification of total lipids from animal tissue
28. Methods to determine oxidation of low-density lipoproteins
29. Lipoprotein classes and coronary disease regression
30. Familial hypercholesterolaemia regression study: A randomised trial of low density lipoprotein apheresis
31. LDL oxidation in patients with severe carotid atherosclerosis: A study of in vitro and in vivo oxidation markers
32. Autoantibodies to glycosylated proteins in the plasma of patients with diabetes mellitus
33. Paraoxonase and coronary heart disease
34. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells
35. Low density lipoprotein subclasses patterns and risk of myocardial infarction
36. Lack of plasma lipid peroxidation during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation
37. The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability
38. Acute effect of H.E.L.P. treatment on radical scavenging enzyme activities, total glutathione concentrations in granulocytes, and selenium in plasma
39. Antioxidant status of hypercholesterolemic patients treated with LDL apheresis
40. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolaemia treated by LDL apheresis